← Scroll for more →
Cumberland Pharmaceuticals Inc (CPIX)
Pharmaceutical Preparations
Latest Price
$7.83
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.16
P/B Ratio
6.73
Valuation metrics
adjust assumptions →Base FCF: $6M (median of recent 5yr)
Growth: 22%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$24.28
+210% upside
Institutional Ownership
17.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 503.2K | $3.0M | 3.36% | -50.0K | 2026-06-30 |
| Renaissance Technologies LLC | 478.3K | $3.0M | 3.19% | +7.6K | 2026-06-30 |
| Vanguard Capital Management LLC | 379.5K | $2.0M | 2.53% | +17.7K | 2026-06-30 |
| Dimensional Fund Advisors LP | 233.3K | $1.0M | 1.56% | -43.1K | 2026-06-30 |
| Boothbay Fund Management, LLC | 112.5K | -- | 0.75% | -15.2K | 2026-06-30 |
| Jane Street Group, LLC | 111.6K | -- | 0.75% | +52.7K | 2026-06-30 |
| Geode Capital Management, LLC | 108.4K | -- | 0.72% | -5.9K | 2026-06-30 |
| Perceptive Advisors LLC | 97.0K | -- | 0.65% | -100.0K | 2026-06-30 |
| Citadel Advisors LLC | 96.5K | -- | 0.64% | +46.7K | 2026-06-30 |
| BlackRock, Inc. | 63.5K | -- | 0.42% | +6.7K | 2026-06-30 |